An in-depth analysis of the new medical insurance reimbursement policy for Eltrombopag/Eltrombopag

Eltrombopag/Eltrombopag, a thrombopoietin receptor agonist (TPO-RA), has appeared in the domestic market and has been officially included in the medical insurance catalog and is classified as a Class B drug in the medical insurance. This is undoubtedly good news for the majority of patients who need to receive eltrombopag treatment, which means that the cost of treatment will be significantly reduced. However, this does not mean that patients in all regions will enjoy the same reimbursement ratio.

According to the medical insurance policies and economic levels of different regions, the reimbursement ratio of eltrombopag varies greatly. This means that even for the same drug, what patients actually pay in different regions can be very different. Therefore, before purchasing drugs, patients should first understand the local medical insurance policies and reimbursement ratios in order to make a more economical and reasonable choice.

The medical insurance reimbursement conditions of eltrombopag currently mainly apply to two groups of people: one is adults and children aged 6 and above with chronic immune (idiopathic) thrombocytopenia (ITP) who have poor response to traditional treatments such as glucocorticoids and immunoglobulins; the other is patients with severe aplastic anemia (SAA) whose immunosuppressive treatment has insufficient relief. This means that only patients who meet these conditions can enjoy medical insurance reimbursement.

In terms of price, the original drug of Eltrombopag is mainly available in the domestic market. There are two specifications: 25mg 14 tablets and 25mg 28 tablets. The price of each box is roughly between 2,000 and 4,000 yuan. However, in overseas markets, such as Türkiye and India, the price of original drugs may be more affordable, about more than 1,000 yuan per box. In addition, Bangladesh, Laos and other places have also produced generic drugs of eltrombopag. The price of these generic drugs may be more affordable, and each box may be sold for around a few hundred yuan.